Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings

References

• Baltussen, R. (2006). Priority setting of public spending in developing countries: Do not try to do everything for everybody. Health Policy, 78(2–3), 149–156. doi:S0168-8510(05)00247-2 [pii] 10.1016/j.healthpol.2005.10.006 doi: 10.1016/j.healthpol.2005.10.006
   PubMed Web of Science ®Google Scholar
• Baltussen, R., & Niessen, L. (2006). Priority setting of health interventions: The need for multi-criteria decision analysis. Cost Effectiveness and Resource Allocation, 4, 14. doi:1478-7547-4-14 [pii] 10.1186/1478-7547-4-14 doi: 10.1186/1478-7547-4-14
   PubMedGoogle Scholar
• Baltussen, R., Stolk, E., Chisholm, D., & Aikins, M. (2006). Towards a multi-criteria approach for priority setting: An application to Ghana. Health Economics, 15(7), 689–696. doi:10.1002/hec.1092
   PubMed Web of Science ®Google Scholar
• Birch, S., & Gafni, A. (2006). The biggest bang for the buck or bigger bucks for the bang: The fallacy of the cost-effectiveness threshold. Journal of Health Services Research & Policy, 11(1), 46–51. doi:10.1258/135581906775094235
   PubMedGoogle Scholar
• Bitton, A., & Eyal, N. (2011). Too poor to treat? the complex ethics of cost-effective tobacco policy in the developing world. Public Health Ethics, 4(2), 109–120. doi:10.1093/phe/phr014
   Web of Science ®Google Scholar
• Bleichrodt, H. (1997). Health utility indices and equity considerations. Journal of Health Economics, 16(1), 65–91. doi:S0167629696005085 [pii] doi: 10.1016/S0167-6296(96)00508-5
   PubMed Web of Science ®Google Scholar
• Bleichrodt, H., Herrero, C., & Pinto, J. L. (2002). A proposal to solve the comparability problem in cost-utility analysis. Journal of Health Economics, 21(3), 397–403. doi:S0167-6296(01)00136-9 [pii] doi: 10.1016/S0167-6296(01)00136-9
   PubMed Web of Science ®Google Scholar
• Bobinac, A., van Exel, N. J., Rutten, F. F., & Brouwer, W. B. (2012). Inquiry into the relationship between equity weights and the value of the QALY. Value in Health, 15(8), 1119–1126. doi:10.1016/j.jval.2012.07.002 S1098-3015(12)01666-X [pii]
   PubMed Web of Science ®Google Scholar
• Braveman, P., & Gruskin, S. (2003). Defining equity in health. Journal of Epidemiology & Community Health, 57(4), 254–258. doi: 10.1136/jech.57.4.254
   PubMed Web of Science ®Google Scholar
• Brock, D. (2004). Ethical issues in the use of cost effectiveness analysis for the prioritization of health resources. In G. Khushf (Ed.), Handbook of bioethics (pp. 353–380). Dordrecht: Springer.
   Google Scholar
• Cleary, S., Mooney, G., & McIntyre, D. (2010). Equity and efficiency in HIV-treatment in South Africa: The contribution of mathematical programming to priority setting. Health Economics, 19(10), 1166–1180. doi:10.1002/hec.1542
   PubMed Web of Science ®Google Scholar
• Creese, A., Floyd, K., Alban, A., & Guinness, L. (2002). Cost-effectiveness of HIV/AIDS interventions in Africa: A systematic review of the evidence. The Lancet, 359(9318), 1635–1642. doi:S0140-6736(02)08595-1 [pii] 10.1016/S0140-6736(02)08595-1 doi: 10.1016/S0140-6736(02)08595-1
   PubMed Web of Science ®Google Scholar
• Dhaliwal, I., Duflo, E., Glennerster, R., & Tulloch, C. (2011). Comparative cost-effectiveness analysis to inform policy in developing countries: A general framework with applications for education.
   Google Scholar
• Dolan, P. (1998). The measurement of individual utility and social welfare. Journal of Health Economics, 17(1), 39–52. doi:S0167629697000222 [pii] doi: 10.1016/S0167-6296(97)00022-2
   PubMed Web of Science ®Google Scholar
• Dolan, P., Metcalfe, R., Munro, V., & Christensen, M. C. (2008). Valuing lives and life years: Anomalies, implications, and an alternative. Health Econ Policy Law, 3(Pt 3), 277–300. doi:10.1017/S1744133108004507 S1744133108004507 [pii]
   PubMed Web of Science ®Google Scholar
• Drummond, M. F., Sculpher, M., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). New York: Oxford University Press.
   Google Scholar
• Eichler, H. G., Kong, S. X., Gerth, W. C., Mavros, P., & Jönsson, B. (2004). Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value in Health, 7(5), 518–528. doi:10.1111/j.1524-4733.2004.75003.x S1098-3015(10)60216-1 [pii]
   PubMed Web of Science ®Google Scholar
• Fox Rushby, J. (2002). Disability adjusted life years (DALYs) for decision-making? An overview of the literature. London: Office of Health Economics.
   Google Scholar
• Fryback, D. G., & Lawrence Jr., W. F. (1997). Dollars may not buy as many QALYs as we think: A problem with defining quality-of-life adjustments. Medical Decision Making, 17(3), 276–284. doi: 10.1177/0272989X9701700303
   PubMed Web of Science ®Google Scholar
• Global Fund Disbursements by Region, Country and Grant Agreement (in USD equivalents). (2012). Retrieved from https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CDMQFjAA&url=http%3A%2F%2Fwww.theglobalfund.org%2Fdocuments%2Fcore%2Fgrants%2Fcore_disbursementdetails_report_en%2F&ei=uaVXUem7MIbW9QShi4DQAg&usg=AFQjCNGKJXSqJ4y1xIfu8ViaS6mUbhvinA&sig2=1T5muMOtt3pWVekQ2S-dnA&bvm=bv.44442042,d.eWU
   Google Scholar
• Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York, NY: Oxford University Press.
   Google Scholar
• Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000). Willingness to pay for a quality-adjusted life year: In search of a standard. Medical Decision Making, 20(3), 332–342. doi: 10.1177/0272989X0002000310
   PubMed Web of Science ®Google Scholar
• James, K. C., & Foster, S. D. (1999). Weighing up disability. The Lancet, 354(9173), 87–88. doi:S0140-6736(99)90060-0 [pii] 10.1016/S0140-6736(99)90060-0
   PubMed Web of Science ®Google Scholar
• Jamison, D., Breman, J., & Measham, A. (Eds.). (2006). Priorities in health, chapter 3, cost-effectiveness analysis. Washington, DC: World Bank.
   Google Scholar
• Jamison, D., Breman, J., Measham, A. R., Alleyne, G., Claeson, M., Evans, D. B., … Musgrove, P. (Eds.). (2006). Disease control priorities in developing countries (2nd ed.). Washington, DC: The World Bank and Oxford University Press.
   Google Scholar
• Jehu-Appiah, C., Baltussen, R., Acquah, C., Aikins, M., d’Almeida, S. A., Bosu, W. K., … Adjei, S. (2008). Balancing equity and efficiency in health priorities in Ghana: The use of multicriteria decision analysis. Value in Health, 11(7), 1081–1087. doi:10.1111/j.1524-4733.2008.00392.x VHE392 [pii]
   PubMed Web of Science ®Google Scholar
• Jelsma, J., Chivaura, V. G., Mhundwa, K., De Weerdt, W., & de Cock, P. (2000). The global burden of disease disability weights. The Lancet, 355(9220), 2079–2080. doi:S0140-6736(05)73538-8 [pii] 10.1016/S0140-6736(05)73538-8 doi: 10.1016/S0140-6736(05)73538-8
   PubMed Web of Science ®Google Scholar
• Jerven, M. (2013). How we are misled by African development statistics and what to do about it. Ithaca, NY: Cornell University Press.
   Google Scholar
• Johannesson, M., & Meltzer, D. (1998). Editorial: Some reflections on cost-effectiveness analysis. Health Economics, 7(1), 1–7. doi:10.1002/(SICI)1099-1050(199802)7:1<1::AID-HEC327>3.0.CO;2-U [pii]
   PubMed Web of Science ®Google Scholar
• Johri, M., & Norheim, O. F. (2012). Can cost-effectiveness analysis integrate concerns for equity? Systematic review. International Journal of Technology Assessment in Health Care, 28(2), 125–132. doi:10.1017/S0266462312000050 S0266462312000050 [pii]
   PubMed Web of Science ®Google Scholar
• Kapiriri, L., Arnesen, T., & Norheim, O. F. (2004). Is cost-effectiveness analysis preferred to severity of disease as the main guiding principle in priority setting in resource poor settings? The case of Uganda. Cost Effectiveness and Resource Allocation, 2(1), 1. doi:10.1186/1478-7547-2-1 1478-7547-2-1 [pii]
   PubMedGoogle Scholar
• Kapiriri, L., & Norheim, O. F. (2004). Criteria for priority-setting in health care in Uganda: Exploration of stakeholders’ values. Bull World Health Organ, 82(3), 172–179. doi:S0042-96862004000300006 [pii]
   PubMed Web of Science ®Google Scholar
• Kapiriri, L., Robbestad, B., & Frithjof Norheim, O. (2003). The relationship between prevention of mother to child transmission of HIV and stakeholder decision making in Uganda: Implications for health policy. Health Policy, 66(2), 199–211. doi:S0168851003000629 [pii] doi: 10.1016/S0168-8510(03)00062-9
   PubMed Web of Science ®Google Scholar
• King Jr., J. T., Tsevat, J., & Roberts, M. S. (2004). Positive association between current health and health values for hypothetical disease states. Medical Decision Making, 24(4), 367–378. doi:10.1177/0272989X04267692
   PubMed Web of Science ®Google Scholar
• Lasry, A., Carter, M. W., & Zaric, G. S. (2011). Allocating funds for HIV/AIDS: A descriptive study of KwaDukuza, South Africa. Health Policy and Planning, 26(1), 33–42. doi:10.1093/heapol/czq022 czq022 [pii]
   PubMed Web of Science ®Google Scholar
• Making choices in health: WHO Guide to Cost-effectiveness Analysis. (2003). Geneva, Switzerland.
   Google Scholar
• Mont, D. (2007). Measuring health and disability. The Lancet, 369(9573), 1658–1663. doi:S0140-6736(07)60752-1 [pii] 10.1016/S0140-6736(07)60752-1 doi: 10.1016/S0140-6736(07)60752-1
   PubMed Web of Science ®Google Scholar
• Mshana, S., Shemilu, H., Ndawi, B., Momburi, R., Olsen, O. E., Byskov, J., & Martin, D. K. (2007). What do district health planners in Tanzania think about improving priority setting using ‘Accountability for reasonableness’?. BMC Health Services Research, 7, 180. doi:1472-6963-7-180 [pii] 10.1186/1472-6963-7-180 doi: 10.1186/1472-6963-7-180
   PubMed Web of Science ®Google Scholar
• Murray, C. J., & Lopez, A. D. (1996). The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2002. Cambridge: Harvard School of Public Health.
   Google Scholar
• Nord, E. (2015). Cost-value analysis of health interventions: Introduction and update on methods and preference data. Pharmacoeconomics, 33(2), 89–95. doi:10.1007/s40273-014-0212-4
   PubMed Web of Science ®Google Scholar
• Nord, E., & Johansen, R. (2014). Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY. Health Policy, 116(2-3), 281–288. doi:10.1016/j.healthpol.2014.02.009 S0168-8510(14)00056-6 [pii]
   PubMed Web of Science ®Google Scholar
• Nord, E., Pinto, J. L., Richardson, J., Menzel, P., & Ubel, P. (1999). Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Economics, 8(1), 25–39. doi:10.1002/(SICI)1099-1050(199902)8:1<25::AID-HEC398>3.0.CO;2-H [pii]
   PubMed Web of Science ®Google Scholar
• Norheim, O. F., Baltussen, R., Johri, M., Chisholm, D., Nord, E., Brock, D., … Wikler, D. (2014). Guidance on priority setting in health care (GPS-Health): The inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Effectiveness and Resource Allocation, 12, 18. doi:10.1186/1478-7547-12-18 1478-7547-12-18 [pii]
   PubMed Web of Science ®Google Scholar
• Ottersen, T., Mbilinyi, D., Mæstad, O., & Norheim, O. F. (2008). Distribution matters: Equity considerations among health planners in Tanzania. Health Policy, 85(2), 218–227. doi:S0168-8510(07)00171-6 [pii] 10.1016/j.healthpol.2007.07.012 doi: 10.1016/j.healthpol.2007.07.012
   PubMed Web of Science ®Google Scholar
• Pinkerton, S., Johnson-Masotti, A., Derse, A., & Layde, P. (2002). Ethical issues in cost-effectiveness analysis. Evaluation and Program Planning, 25(1), 71–83. doi: 10.1016/S0149-7189(01)00050-7
   Web of Science ®Google Scholar
• Rawls, J. (1971). A theory of justice. Cambridge, MA: Harvard University Press.
   Google Scholar
• Reichenbach, L. (2002). The politics of priority setting for reproductive health: Breast and cervical cancer in Ghana. Reproductive Health Matters, 10(20), 47–58. doi: 10.1016/S0968-8080(02)00093-9
   PubMed Web of Science ®Google Scholar
• Salomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012). Healthy life expectancy for 187 countries, 1990-2010: A systematic analysis for the Global Burden Disease Study 2010. The Lancet, 380(9859), 2144–2162. doi:10.1016/S0140-6736(12)61690-0 S0140-6736(12)61690-0 [pii]
   PubMed Web of Science ®Google Scholar
• Sassi, F., Archard, L., & Le Grand, J. (2001). Equity and the economic evaluation of healthcare. Health Technology Assessment, 5(3), 1–138. doi: 10.3310/hta5030
   PubMedGoogle Scholar
• Sendi, P. P., & Briggs, A. H. (2001). Affordability and cost-effectiveness: Decision-making on the cost-effectiveness plane. Health Economics, 10(7), 675–680. 10.1002/hec.639 [pii] doi: 10.1002/hec.639
   PubMed Web of Science ®Google Scholar
• Shiffman, J. (2006). Donor funding priorities for communicable disease control in the developing world. Health Policy and Planning, 21(6), 411–420. doi: czl028 [pii] 10.1093/heapol/czl028 doi: 10.1093/heapol/czl028
   PubMed Web of Science ®Google Scholar
• Shillcutt, S. D., Walker, D. G., Goodman, C. A., & Mills, A. J. (2009). Cost effectiveness in low- and middle-income countries: A review of the debates surrounding decision rules. Pharmacoeconomics, 27(11), 903–917. doi:10.2165/10899580-000000000-00000 3 [pii]
   PubMed Web of Science ®Google Scholar
• Thokala, P., & Duena, A. (2012). Multiple criteria decision analysis for health technology assessment. Value Health, 15(8), 1172–1181. doi: 10.1016/j.jval.2012.06.015
   PubMed Web of Science ®Google Scholar
• Tsuchiya, A. (1999). Age-related preferences and age weighting health benefits. Social Science & Medicine, 48(2), 267–276. doi: S0277953698003438 [pii] doi: 10.1016/S0277-9536(98)00343-8
   PubMed Web of Science ®Google Scholar
• Ubel, P. A., DeKay, M. L., Baron, J., & Asch, D. A. (1996). Cost-effectiveness analysis in a setting of budget constraints — is it equitable? New England Journal of Medicine, 334(18), 1174–1177. doi:10.1056/NEJM199605023341807
   PubMed Web of Science ®Google Scholar
• Ubel, P. A., Nord, E., Gold, M., Menzel, P., Prades, J. L. P., & Richardson, J. (2000). Improving value measurement in cost-effectiveness analysis. Medical Care, 38(9), 892–901. doi:10.1097/00005650-200009000-00003
   PubMed Web of Science ®Google Scholar
• Üstün, T. B., Rehm, J., Chatterji, S., Saxena, S., Trotter, R., Room, R., & Bickenbach, J. (1999). Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group. The Lancet, 354(9173), 111–115. doi:S0140673698075072 [pii] doi: 10.1016/S0140-6736(98)07507-2
   PubMed Web of Science ®Google Scholar
• Wagstaff, A. (1991). QALYs and the equity-efficiency trade-off. Journal of Health Economics, 10(1), 21–41. doi: 10.1016/0167-6296(91)90015-F
   PubMed Web of Science ®Google Scholar
• Whitehead, M. (1992). The concepts and principles of equity and health. International Journal of Health Services, 22(3), 429–445. doi: 10.2190/986L-LHQ6-2VTE-YRRN
   PubMed Web of Science ®Google Scholar
• WHO. (2005). Choosing interventions that are cost effective: Cost-effectiveness thresholds. Geneva: Author.
   Google Scholar
• Williams, A. (1992). Cost-effectiveness analysis: Is it ethical? Journal of Medical Ethics, 18(1), 7–11. doi: 10.1136/jme.18.1.7
   PubMed Web of Science ®Google Scholar
• Williams, A. (1997). Intergenerational equity: An exploration of the ‘fair innings’ argument. Health Economics, 6(2), 117–132. doi:10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B [pii]
   PubMed Web of Science ®Google Scholar
• The World Factbook. (2013). Retrieved from https://www.cia.gov/library/publications/the-world-factbook/rankorder/2004rank.html
   Google Scholar